Profile data is unavailable for this security.
About the company
Aarti Pharmalabs Limited is a manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), xanthine derivatives, and allied products, situated in India. The Company delivers contract development and manufacturing organization (CDMO) services for drug substance/NCE development and manufacturing for pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of corticosteroids, cytotoxic medicines, and oncology products. Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its range of intermediate products include Abemaciclib Intermediate, Acalabrutinib Intermediate, Afatinib Intermediate, Apalutamide Intermediate, Azathioprine Intermediate, and others. Its Caffeine products include caffeine anhydrous, and caffeine anhydrous (granules).
- Revenue in INR (TTM)19.50bn
- Net income in INR2.25bn
- Incorporated2019
- Employees1.63k
- LocationAarti Pharmalabs LtdMUMBAI 400080IndiaIND
- Phone+91 2 269436100
- Fax+91 2 267976660
- Websitehttps://www.aartipharmalabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indoco Remedies Ltd | 18.22bn | 766.90m | 31.38bn | 5.93k | 41.28 | -- | 18.02 | 1.72 | 8.25 | 8.25 | 178.33 | -- | -- | -- | -- | 3,072,462.00 | -- | 6.88 | -- | 9.85 | 68.61 | 65.59 | 4.10 | 6.93 | -- | 2.95 | -- | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
Solara Active Pharma Sciences Ltd | 13.00bn | -5.61bn | 31.83bn | 2.16k | -- | -- | -- | 2.45 | -143.75 | -143.75 | 334.17 | -- | -- | -- | -- | 6,030,149.00 | -- | -2.44 | -- | -3.84 | 37.34 | 41.16 | -43.17 | -4.49 | -- | -1.57 | -- | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 39.15bn | 1.23k | -- | 123.84 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
Gufic BioSciences Ltd | 8.14bn | 863.69m | 39.36bn | 1.45k | 45.13 | -- | 38.04 | 4.83 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
Innova Captab Ltd | 11.42bn | 1.06bn | 41.36bn | -- | 30.51 | -- | 33.29 | 3.62 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
Hikal Ltd | 18.03bn | 677.82m | 41.87bn | 2.06k | 61.80 | -- | 22.10 | 2.32 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
RPG Life Sciences Limited | 6.00bn | 923.20m | 45.74bn | 1.27k | 49.54 | -- | 41.41 | 7.63 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
Aarti Drugs Ltd | 24.23bn | 1.57bn | 46.55bn | 1.06k | 29.86 | -- | 22.26 | 1.92 | 17.08 | 17.08 | 263.82 | -- | -- | -- | -- | 22,770,740.00 | -- | 9.73 | -- | 15.78 | 34.32 | 22.23 | 6.48 | 8.25 | -- | 7.28 | -- | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
Unichem Laboratories Ltd | 17.28bn | -605.50m | 47.11bn | 3.19k | -- | -- | 90.17 | 2.73 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
Supriya Lifescience Ltd | 5.99bn | 1.35bn | 47.18bn | 448.00 | 34.90 | -- | 31.09 | 7.88 | 16.80 | 16.80 | 74.42 | -- | -- | -- | -- | 13,370,000.00 | -- | 19.08 | -- | 24.04 | 62.75 | 57.12 | 22.58 | 24.71 | -- | 92.47 | -- | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
SeQuent Scientific Ltd | 14.27bn | 54.87m | 48.19bn | 1.20k | 905.27 | -- | 62.04 | 3.38 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
Morepen Laboratories Ltd | 17.45bn | 1.18bn | 48.74bn | 1.62k | 38.49 | -- | 32.57 | 2.79 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
Aarti Pharmalabs Ltd | 19.50bn | 2.25bn | 55.29bn | 1.63k | 24.54 | -- | 18.34 | 2.84 | 24.86 | 24.86 | 215.17 | -- | -- | -- | -- | 11,983,730.00 | -- | -- | -- | -- | 44.20 | -- | 11.55 | -- | -- | 18.55 | -- | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Sun Pharma Advanced Research Co Ltd | 684.05m | -3.89bn | 66.90bn | 409.00 | -- | -- | -- | 97.79 | -11.97 | -11.97 | 2.11 | -- | -- | -- | -- | 1,672,501.00 | -- | -61.70 | -- | -119.31 | 59.81 | 74.49 | -568.24 | -163.40 | -- | -208.33 | -- | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
Orchid Pharma Ltd | 8.81bn | 1.12bn | 70.31bn | 872.00 | 60.57 | -- | 47.98 | 7.98 | 22.89 | 22.89 | 180.65 | -- | -- | -- | -- | 10,101,540.00 | -- | -0.9734 | -- | -1.40 | 40.67 | 40.74 | 12.78 | -2.40 | -- | 6.08 | -- | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
Holder | Shares | % Held |
---|---|---|
quant Money Managers Ltd.as of 31 Jul 2024 | 2.71m | 2.99% |
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Jul 2024 | 954.62k | 1.05% |
Morgan Stanley Investment Management Co.as of 30 Jun 2024 | 925.18k | 1.02% |
BlackRock Fund Advisorsas of 04 Jul 2024 | 732.52k | 0.81% |
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jul 2024 | 496.33k | 0.55% |
Dimensional Fund Advisors LPas of 04 Jul 2024 | 434.22k | 0.48% |
Norges Bank Investment Managementas of 31 Dec 2023 | 341.42k | 0.38% |
BlackRock Advisors (UK) Ltd.as of 04 Jul 2024 | 130.42k | 0.14% |
Mellon Investments Corp.as of 03 Jul 2024 | 97.96k | 0.11% |
Motilal Oswal Asset Management Co. Ltd.as of 31 Jul 2024 | 89.57k | 0.10% |